News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Gerard Walls: Fabulous ESTRO 2025 Opener from Gerry Hanna
Collage photo of Gerard Walls and Gerry Hanna
May 2, 2025, 15:24

Gerard Walls: Fabulous ESTRO 2025 Opener from Gerry Hanna

Gerard Walls, Clinical Senior Lecturer and Honorary Consultant in Clinical Oncology at Queen’s University Belfast, shared a post on X:

“Fabulous ESTRO25 opener from Gerry Hanna on building successful interdisciplinary research teams at the RTT pre-meeting course.”

Gerard Walls: Fabulous ESTRO 2025 Opener from Gerry Hanna

ESTRO 2025 Live Updates on OncoDaily.

cancer ESTRO 2025 Gerard Walls Gerry Hanna OncoDaily Oncology
Special Coverage
Blog
Jun 20, 2025, 03:55
Nicolas Hart: Presenting on Cancer Survivorship at Wolper Jewish Hospital
Drugs
Jun 20, 2025, 02:19
Is Tamoxifen Chemotherapy? Understanding Its Role in Breast Cancer Treatment
Blog
Jun 19, 2025, 17:36
ESTRO Introduces KAYAC+ to Advance Radiation Therapy For Adolescents And Young Adults With Cancer
Blog
Jun 19, 2025, 17:26
XVII CCI LATAM Conference Was a Celebration Of a Growing Community, Unity, and Hope - Childhood Cancer International
Blog
Jun 19, 2025, 17:07
Join The AI For Everyone, Everywhere, Let’s talk about Large Language Models Meeting - SIOP
Blog
Jun 19, 2025, 16:57
David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients
Blog
Jun 19, 2025, 16:21
Neeraj Agarwal: Poor Outcomes with SOC in mHSPC Prostate Cancer Patients With HRR Mutation
Blog
Jun 19, 2025, 16:12
World Kidney Cancer Day 2025: Uniting for Progress in the Fight Against Renal Cell Carcinoma
Blog
Jun 19, 2025, 16:01
IARC Marks World Kidney Cancer Day with New Video and Project Highlights
Science
Jun 19, 2025, 15:50
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Opinion
Jun 19, 2025, 15:47
Mostafa Faisal: Primary Refractory AML and Allo-HCT - A 10-Year Retrospective Study from Japan
Blog
Jun 19, 2025, 15:36
Amol Akhade: KEYNOTE-689 - A Turning Point in Resectable HNSCC - Or a Cautious Step Forward?